Health ❯ Healthcare ❯ Chronic Diseases

Obesity

Weight Management Type 2 Diabetes Economic Impact of Obesity Semaglutide Patient Care Diet and Nutrition Youth Health Weight Management Strategies Management Health Programs Weight Loss Treatments Health Complications Nonalcoholic Fatty Liver Disease Obesity-related Cancer Obesity Management Health Risks Metabolic Disorders Heart Disease Public Health Global Health Challenges Cardiovascular Health Cardiovascular Risk Obesity Treatments Impact on Heart Failure Treatment Strategies Treatment Options Weight Loss Strategies MariTide Childhood Obesity Diabetes Management Strategies

Oral Semaglutide 25 mg Shows Larger Metabolic Gains With At Least 15% Weight Loss in OASIS-4

An exploratory analysis presented at ObesityWeek 2025 links greater weight reduction to bigger improvements in glycemia plus cardiovascular risk markers.

Innovent Says Mazdutide Tops Semaglutide in China Phase 3 Diabetes Trial